RAW264.7 cells and
A549 cells were purchased from American Type Culture Collection (Manassas, VA, USA) and cultured in either arginine-free DMEM (Thermo Fisher Scientific Life Sciences, Waltham, MA, USA) or standard DMEM (containing 400 µM
l-arginine; Sigma-Aldrich, St. Louis, MO, USA), both supplemented with
fetal calf serum (10%; LabTech, Uckfield, United Kingdom). Confluent cultures were treated with LPS (
RAW264.7 cells; 1 μg/ml; Sigma-Aldrich) or
IL-1β (
A549 cells; 10 ng/ml; R&D Systems, Minneapolis, MN, USA) for 24 h to induce iNOS and COX-2, in some cases in the presence of the NOS inhibitors,
l-NAME (300 μM; Sigma-Aldrich) or ADMA (1 mM; Sigma-Aldrich). Increasing concentrations of ibuprofen arginate (Zambon Pharma),
ibuprofen sodium (Sigma-Aldrich),
l-arginine free base (Sigma-Aldrich), or the combination of
ibuprofen sodium and
l-arginine were also added such that the molar concentration of
l-arginine present in each preparation was the same, or for
ibuprofen sodium, the molar concentration of ibuprofen. After 24 h, media were collected for measurement of nitrite accumulation using the
Griess reaction (Sigma-Aldrich) or PGE
2 using immunoassay (Cisbio, Codolet, France). Cell viability was assessed using the alamarBlue metabolic activity assay (Thermo Fisher Scientific).
Kirkby N.S., Tesfai A., Ahmetaj-Shala B., Gashaw H.H., Sampaio W., Etelvino G., Leão N.M., Santos R.A, & Mitchell J.A. (2016). Ibuprofen arginate retains eNOS substrate activity and reverses endothelial dysfunction: implications for the COX-2/ADMA axis. The FASEB Journal, 30(12), 4172-4179.